Assignee
ISOFOL MEDICAL AB
SE·9 granted patents·8 pending applications·19 citations·filing 2013–2023
Top patents by PatentIndex Score
17 records- 0186US10328079B2[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapyISOFOL MEDICAL AB·Filed 2018·Granted Jun 25, 2019·3 cites·23 claims
- 0286US10292984B2Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibitionISOFOL MEDICAL AB·Filed 2018·Granted May 21, 2019·4 cites·16 claims
- 0383US9675617B2Tetrahydrofolates in combination with EGFR-inhibitorsISOFOL MEDICAL AB·Filed 2013·Granted Jun 13, 2017·6 cites·19 claims
- 0481US10639311B2Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibitionISOFOL MEDICAL AB·Filed 2019·Granted May 5, 2020·2 cites·13 claims
- 0580US11389452B2Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibitionISOFOL MEDICAL AB·Filed 2020·Granted Jul 19, 2022·1 cites·41 claims
- 0679US11013744B2[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapyISOFOL MEDICAL AB·Filed 2018·Granted May 25, 2021·3 cites·15 claims
- 0763US2019212341A1Methods for treating colorectal and metastatic colorectal cancersISOFOL MEDICAL AB·Filed 2019·Application pending·0 cites
- 0862US12527796B2[6R]-MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapyISOFOL MEDICAL AB·Filed 2021·Granted Jan 20, 2026·0 cites·14 claims
- 0959US2023116137A1Methods for treating colorectal and metastatic colorectal cancersISOFOL MEDICAL AB·Filed 2022·Application pending·0 cites
- 1058US2023097085A1[6r]-mthf in 5-fu based chemotherapy of right-sided colorectal cancerISOFOL MEDICAL AB·Filed 2021·Application pending·0 cites
- 1158US2023095428A1[6r]-mthf in 5-fu based chemotherapy of braf- or kras-mutated colorectal cancerISOFOL MEDICAL AB·Filed 2021·Application pending·0 cites
- 1257US2023102483A1[6r]-mthf in 5-fu based chemotherapy of left-sided colorectal cancerISOFOL MEDICAL AB·Filed 2021·Application pending·0 cites
- 1356US2024350467A1[6r]-mthf in b6 enhanced 5-fu based chemotherapy of pancreatic cancerISOFOL MEDICAL AB·Filed 2023·Application pending·0 cites
- 1456US2024350495A1[6r]-mthf in b6 enhanced 5-fu based chemotherapy of carcinomaISOFOL MEDICAL AB·Filed 2023·Application pending·0 cites
- 1553US10487364B2Administration regimeISOFOL MEDICAL AB·Filed 2015·Granted Nov 26, 2019·0 cites·6 claims
- 1653US9585888B2Reduction of toxicity of multi-targeting antifolatesISOFOL MEDICAL AB·Filed 2015·Granted Mar 7, 2017·0 cites·10 claims
- 1737US2015018361A1Anti-tumor activity of reduced folates like methylene-tetrahydrofolateISOFOL MEDICAL AB·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →